Antigen receptor signal transduction: Activating and inhibitory antigen receptors regulate STAT1 serine phosphorylation

European Journal of Immunology

Volumn 30, Issue 7, 2000, Pages 1851-1860

  Lafont, Virginie ^b   Decker, Thomas ^a   Cantrell, Doreen ^b  

^a Vienna Biocenter   (Austria)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Antigen receptor; Serine kinase; STAT

Indexed keywords

FC RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE KINASE; PROTEIN TYROSINE KINASE; SERINE; STAT1 PROTEIN; TRANSCRIPTION FACTOR; TYROSINE;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE; MAMMAL; MULTIGENE FAMILY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; 1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIGENS, CD; DNA; DNA-BINDING PROTEINS; HUMANS; JURKAT CELLS; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IGG; SERINE; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0033938118     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200007)30:7<1851::AID-IMMU1851>3.0.CO;2-C     Document Type: Article

References (39)

1. Weiss, A. and Littman, D. R., Signal transduction by lymphocyte antigen receptors. Cell 1994. 76: 263-274.
2. Wange, R. L. and Samelson, L. E., Complex complexes: signaling at the TCR. Immunity 1996. 5: 197-205.
3. Kurosaki, T., Molecular mechanisms in B cell antigen receptor signaling. Curr. Opin. Immunol. 1997. 9: 309-318.
4. Matthews, S., Rozengurt, E. and Cantrell, D., Characterisation of Serine 916 as an in vivo autophosphorylation site for PKD/PKCμ. J. Biol. Chem. 1999. 274: 26543-26549.
5. Ward, S. G., June, C. H. and Olive, D., PI 3-kinase: a pivotal pathway in T cell activation. Immunol. Today 1996. 17: 187-198.
6. Li, Z., Wahl, M. I., Eguinoa, A., Stephens, L. R., Hawkins, P. T. and Witte, O. N., Phosphatidylinositol 3-kinase-gamma activates Bruton's tyrosine kinase in concert with Src family kinases. Proc. Natl. Acad. Sci. USA 1997. 9: 13820-13825.
7. Reif, K., Burgering, B. M. T. and Cantrell, D. A., Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase. J. Biol. Chem. 1997. 272: 14426-14438.
8. Astoul, E., Watton, S. and Cantrell, D. A., The dynamics of protein kinase B regulation during B cell antigen receptor engagement. J. Cell Biol. 1999. 145: 1511-1520.
9. Henning, S. W. and Cantrell, D. A., GTPases in antigen receptor signaling. Curr. Opin. Immunol. 1998. 10: 322-329.
10. Izquierdo, M., Bowden, S. and Cantrell, D. A., The role of Raf-1 in the regulation of extracellular signal-related kinase 2 by the T cell antigen receptor. J. Exp. Med. 1994. 180: 401-406.
11. Darnell, J. E., Kerr, I. M. and Stark, G. R., Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994. 264: 1415-1421.
12. O'Shea, J. J., Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 1997. 7: 1-11.
13. Kaplan, M. H. and Grusby, M. J., Regulation of T helper cell differentiation by STAT molecules. J. Leukoc. Biol. 1998. 64: 2-5.
14. Beadling, C., Ng, J., Babbage, J. W. and Cantrell, D. A., Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf-1/ERK2 MAP kinase pathway. EMBO J. 1996, 15: 1902-1913.
15. Moriggl, R., Sexl, V., Piekorz, R., Topham, D. and Ihle, J., Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells. Immunity 1999. 11: 225-230.
16. Bromberg, J. F., Horvath, C. M., Wen, Z., Schreiber, R. D. and Darnell, J. E., Transcriptionally active STAT1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc. Natl. Acad. Sci. USA 1996. 93: 7673-7678.
17. Durbin, J. E., Hackenmiller, R., Simon, M. C. and Levy, D. E., Targeted disruption of the mouse STAT1 gene results in compromised innate immunity to viral disease. Cell 1996. 84: 443-450.
18. Meraz, M. A., White, J. M., Sheehan, K. C., Bach, E. A., Rodig, S. J., Digne, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., Carver-Moore, K., Dubois, R. N., Clark, R., Aguet, M. and Schreiber, R. D., Targeted disruption of the STAT1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996. 83: 431-442.
19. Wen, Z. and Darnell, J. E., Mapping of STAT3 Serine phosphorylation to a single residue (727) and evidence that Serine phosphorylation has no influence on DNA binding of STAT1 and STAT3. Nucleic Acids Res. 1995. 25: 2062-2067.
20. Wen, Z., Zhong, Z. and Darnell, J. E., Maximal activation of transcription by STAT1 and STAT3 requires both tyrosine and Serine phosphorylation. Cell 1995. 82: 241-250.
21. Zhang, J. H., Zhao, Y., Chait, B. T., Lathem, W. W., Ritzi, M., Knippers, R. and Darnell, J. E., Serine727-dependent recruitment of MCM5 by STAT1a in IFN-γ-induced transcriptional activation. EMBO J. 1998. 17: 6963-6971.
22. Kumar, A., Commane, M., Flickinger, T. W., Horvath, C. M. and Stark, G. R., Defective TNF-α-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 1998. 278: 1630-1632.
23. Boulton, T. G., Zhong, Z., Wen, Z., Darnell, J. E., Stahland, N. and Yancopoulos, G. D., STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring H7-sensitive kinase. Proc. Natl. Acad. Sci. USA 1995. 92: 6915-6919.
24. Chung, J., Uchida, E., Grammer, T. C. and Blenis, J., STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell Biol. 1997. 17: 6508-6516.
25. Ng, J. and Cantrell, D., STAT3 is a serine kinase target in T lymphocytes. J. Biol. Chem. 1997. 272: 24542-24549.
26. Zhu, X., Wen, Z., Xu, L. Z. and Darnell, J. E., STAT1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase. Mol. Cell Biol. 1997. 17: 6618-6623.
27. Kovarik, P., Stoiber, D., Novy, M. and Decker, T., STAT1 combines signals derived from IFN-γ and LPS receptors during macrophage activation. EMBO J. 1998. 17: 3660-3668.
28. Kovarik, P., Stoiber, D., Eyers, P. A., Menghini, R., Neininger, A., Gaestel, M., Cohen, P. and Decker, T., Stress-induced phosporylation of STAT1 at serine727 requires p38 mitogen-activated protein kinase whereas IFN-γ uses a different signaling pathway. Proc. Natl. Acad. Sci. USA 1999. 96: 13956-13961.
29. Beadling, C., Guschin, D., Witthuhn, A., Ziemiecki, A., Ihle, J. N., Kerr, A. and Cantrell, D. A., Activation of JAK kinases and STAT proteins by interleukin-2 and Interferon, but not the T cell antigen receptor, in human T lymphocytes. EMBO J. 1994. 13: 5605-5615.
30. Gonzalez, F. A., Raden, D. L. and Davis, R. J., Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases, J. Biol. Chem. 1991. 266: 22159-22163.
31. Nishiya, T., Uehara, T., Edamatsu, H., Kaziro, Y., Itoh, H. and Nomura, Y., Activation of STAT1 and subsequent transcription of inducible nitric oxide synthase gene in C6 glioma cells is independent of interferon-γ-induced MARK activation that is mediated by p21ras. FEBS Lett 1997. 408: 33-38.
32. Su, L., Rickert, R. C. and David, M., Rapid STAT1 phosphorylation via the B cell receptor - Modulatory role of CD19. J. Biol. Chem. 1999. 274: 31770-31774.
33. Coggeshall, K. M., Inhibitory signaling by B cell Fc gamma RIIb. Curr. Opin. Immunol. 1998. 10: 306-312.
34. Ravetch, J. V., Fc receptors. Curr. Opin. Immunol. 1997. 9: 121-125.
35. Ono, M., Okada, H., Bolland, S., Yanagi, S., Kurosaki, T. and Ravetch, J. V., Deletion of SHIP of SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 1997. 90: 293.
36. Sarao, R., Kozieradzki, I., Ohashi, P., Penninger, J. and Dumont, D., The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling. J. Exp. Med. 1998. 188: 1333-1342.
37. Helgason, C., Damen, J., Rosten, P., Grewal, R., Sorensen, P., Chappel, S., Borowski, A., Jirik, F., Krystal, G. and Humphries, R., Targeted disruption of SHIP leads to hematopoietic perturbations lung pathology, and a shortened life-span. Genes Dev. 1998. 12: 1610-1620.
38. Okada, H., Bolland, S., Hashimoto, A., Kurosaki, M., Kabuyama, Y., Iino, M., Ravetch, J. V. and Kurosaki, T., Cutting edge: role of the inositol phosphatase SHIP in B cell receptor-induced Ca2+ oscillatory response. J. Immunol. 1998. 161: 5129-5132.
39. Lee, C., Gimeno, R. and Levy, D., Differential regulation of constitutive major histocompatibility complex class I expression in T and B lymphocytes. J. Exp. Med. 1999. 190: 1451-1463.